Leonardo Jaimes, MD

All articles by Leonardo Jaimes, MD

• Targeted immunotherapy for FNAIT shows early promise

  A targeted immunotherapy using a specially designed fusion protein for the treatment of FNAIT has shown early promise in animal models.

• Emerging therapies could change FNAIT treatment landscape

  Biologics like nipocalimab will soon offer a targeted approach that could transform FNAIT prevention and management.

• Pathogen reduction technologies could improve FNAIT treatment

  Advancements in the preparation of platelet concentrates, often required to treat FNAIT, have the potential to improve patient care.

• Study: IVIG’s effectiveness in preventing FNAIT varies by case

  IVIG can prevent severe thrombocytopenia in pregnancies complicated with FNAIT, but its efficacy can vary from pregnancy to pregnancy.

• Advanced imaging techniques help determine cause of brain bleeds

  A recent study showed that specific imaging patterns could help physicians determine the cause of neonatal brain bleeds.

• Case report: Infant diagnosed with rare fetal hemorrhage

  Subamniotic hemorrhage, a possible FNAIT complication, poses significant diagnostic challenges, particularly when it presents before birth.

• Utilizing telemedicine may improve outcomes after NICU discharge

  Families of patients with NICU stays due to severe conditions reported telemedicine appointments improved adaptation after discharge.

• Editing immunoglobulin G antibodies could help predict FNAIT severity

  The addition of a sugar molecule (fucosylation) to IgG antibodies could help in determining the severity of alloimmune diseases like FNAIT.

• Study shows high number of FNAIT cases in Ethiopia

  In the study, FNAIT was often associated with other conditions such as preeclampsia, neonatal sepsis and necrotizing enterocolitis.

• Researchers describe signs of rare intracranial hemorrhage subtype

  In a recent study, researchers identified the clinical signs that may point to a rare subtype of intracranial hemorrhage.